Zymeworks, Inc. (ZYME)
24.36
-0.07
(-0.29%)
USD |
NASDAQ |
May 19, 12:00
Zymeworks Profit Margin (Quarterly) : -1.83K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 48.07% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Catalyst Pharmaceuticals, Inc. | 42.66% |
| Vertex Pharmaceuticals, Inc. | 34.24% |
| AbbVie, Inc. | 4.58% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -36.36% |
| Return on Assets | -24.97% |
| Return on Invested Capital | -29.34% |
| Gross Profit Margin (Quarterly) | -18.23% |
| Operating Margin (Quarterly) | -1.96K% |
| Return on Net Operating Assets | -174.7% |